Sage Labs, Caribou Bio Ink Genome Editing Partnership | GenomeWeb

NEW YORK (GenomeWeb News) – Sage Labs said today it has entered into a partnership and licensing agreement that provides it access to Caribou Biosciences' intellectual property related to the CRISPR/Cas9 genome editing system.

As part of the deal, Sage will have exclusive rights to Caribou's IP to produce and sell genetically engineered rats. It also gains non-exclusive rights for mouse and rabbit models.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.